Vassili Kusmartsev
About Vassili Kusmartsev
Vassili Kusmartsev is a Data Scientist with a strong academic background, holding a PhD in Evolutionary Genomics from Imperial College London and a Master's degree in Natural Sciences from the University of Cambridge. He has experience in various roles, including computational biology and data analysis, and currently works at Exscientia in Oxford, England.
Work at Exscientia
Vassili Kusmartsev has been employed at Exscientia as a Data Scientist since 2021. His role involves utilizing data analysis techniques to support the company's mission in drug discovery and development. Exscientia is known for its innovative approach to artificial intelligence in pharmaceutical research, and Kusmartsev contributes to this by applying his expertise in statistical data analysis.
Education and Expertise
Kusmartsev holds a broad 1st class honours degree in Natural Sciences from the University of Cambridge, where he studied from 2012 to 2016. He further advanced his education at Imperial College London, earning a Doctor of Philosophy (PhD) in Evolutionary Genomics from 2016 to 2021. His academic background is complemented by a strong research focus on molecular evolution and proficiency in statistical data analysis and scientific communication.
Background
Vassili Kusmartsev's educational journey began at Loughborough Grammar School, where he completed his high school education from 2005 to 2012. He then attended the University of Cambridge, where he obtained both his undergraduate and master's degrees in Natural Sciences. Following this, he pursued a PhD at Imperial College London, specializing in Evolutionary Genomics, further enhancing his research capabilities.
Previous Work Experience
Before joining Exscientia, Kusmartsev gained diverse work experience. He worked as a Data Entry professional for IBM during the Championships at Wimbledon from 2013 to 2014. He also served as a Computational Biologist at Fluidic Analytics for a brief period in 2021. Additionally, he was a PhD student at the MRC London Institute of Medical Sciences from 2016 to 2021, where he engaged in significant research activities.